Early-Onset Cancer

AACR’s 2025 Report Shows Cancer Survival Gains as Early-Onset Cases Climb, Presses for Sustained U.S. Funding

The 2025 analysis highlights a surge of FDA approvals that broadened treatment options across drugs, devices, tests, plus AI tools.